Nevertheless, the virus contributes to tumor initiation and clonal expansion of infected lymphoid and epithelial cells by inducing specific genetic/epigenetic changes (such as c-myc translocation and loss of CDKN2A/p16) or impairing host immune system (6, 17). Here, CDKN2A is linked to neoplasm.